Exela Technologies, Inc. Reports Third Quarter 2019 Results
- Revenue of
$372.9 million , representing a decline of 2.6% on a reported basis and 1.9%(1) on a constant currency basis from Q3 2018 - Operating loss of
$(96.9) million , including a$99.7 million non-cash impairment charge, compared with operating income of$6.4 million in Q3 2018 - Net loss of
$(133.4) million - EBITDA(2) of
$(70.3) million - Adjusted EBITDA(3) of
$58.5 million on a reported basis;$58.7 million on a constant currency basis - Debt reduction and liquidity improvement initiative approved; intended to increase liquidity to approximately
$125 to $150 million from$50.4 million (4) and to repay debt with a target reduction of$150 to $200 million
“We continue to see good momentum in our business from recent client wins and our pipeline growth remains solid. Our Digital NowSM strategy is adding to our growth, as clients increasingly recognize that digital transformation is essential to remain competitive and improve operating efficiencies,” said
“Our revenue excluding the previously announced low-margin client exit (“LMCE”) and pass through revenues from postage and postage handling with either zero or nominal margins (“pass through revenue”), grew 2.4% in the third quarter and 3.2% year to date(5). We are pleased with this improving trend, which is reflective of our efforts to drive our high-value, recurring revenue businesses,” stated
Mr. Reynolds continued, “Taking into account our consolidated third quarter results, the continued unpredictable nature of our revenue from postage, a slower ramp of certain new projects, and longer than expected sales cycles, we are updating our 2019 guidance. We now expect 2019 revenue of
Third Quarter 2019 Financial Highlights
- Revenue: Revenue was
$372.9 million , a decline of 2.6% from$383.0 million in the third quarter of 2018. Revenue for the Information and Transaction Processing Solutions (“ITPS”) segment was$292.0 million , a decline of 5.0% year-over-year, driven primarily by the previously announced exit of a low margin contract offset by growth from existing customers and new contract ramps. Healthcare Solutions (“HS”) revenue was$62.1 million , an increase of 9.4% year-over-year, consistent with expectations, and driven primarily by new client growth and increased volume with existing clients. Legal and Loss Prevention Services (“LLPS”) revenue was$18.8 million , consistent with the third quarter of 2018.
Revenue excluding the LMCE and pass through revenue was$309.3 million in the third quarter of 2019 and$959.5 million in the first nine months of 2019, representing growth of 2.4% and 3.2%, respectively, over the comparable prior year periods.
- Operating income / (loss): Operating loss for the third quarter of 2019 was
$(96.9) million , compared with operating income of$6.4 million in the third quarter of 2018, primarily driven by non-cash goodwill and trade-name impairment charges of$99.7 million along with lower revenue and higher SG&A expenses that were offset by lower amortization costs. The non-cash goodwill and trade-name impairment charges incurred in the third quarter were related to the write-down of the carrying values of the ITPS and LLPS segments.
- Net Loss: Net Loss for the third quarter of 2019 was
$(133.4) million , compared with a net loss of$(28.9) million in the third quarter of 2018.
- Adjusted EBITDA: Adjusted EBITDA for the third quarter of 2019 was
$58.5 million , a decline of 15.1% as compared to Adjusted EBITDA of$68.9 million in the third quarter of 2018. Adjusted EBITDA margin for the third quarter of 2019 was 15.7% compared to Adjusted EBITDA margin of 18.0% in the third quarter of 2018. The decrease in third quarter 2019 Adjusted EBITDA was mainly driven by lower revenue in the ITPS segment along with higher SG&A spend and foreign currency losses offset by continued realization of savings flow-through.
Adjusted EBITDA margin, based on revenue excluding the LMCE and pass through revenue, was 18.9% in the third quarter of 2019 and 21.1% in the first nine months of 2019, compared with 22.8% and 22.4% in the comparable prior year periods.
- Capital Expenditures: Capital expenditures for the third quarter of 2019 were 1.8% of revenue compared to 1.7% of revenue in the third quarter of 2018.
- Common Stock: As of
September 30, 2019 , there were 156,101,818 total shares of common stock outstanding which includes 5,402,954 shares reserved for outstanding preferred shares on an as-converted basis.
- Share buyback: During the third quarter of 2019, the Company did not purchase any shares of common stock. Cumulative shares repurchased under the Company’s share buyback program total 2,787,147 since program inception.
- Total employees as of
September 30, 2019 were 22,715 as compared to 23,501 as ofJune 30, 2019 . The decrease in employees is primarily in theAmericas and mostly attributable to savings initiatives.
- 82% of third quarter 2019 revenue was in the
Americas and 18% was inEurope .
Balance Sheet and Liquidity
- At
September 30, 2019 , Exela’s total liquidity was$50.4 million and total net debt was$1.485 billion .
Debt Reduction and Liquidity Improvement
To fund the debt reduction, the Company is pursuing the sale of certain non-core assets. The businesses for which
The Company expects to use the net proceeds from the Initiative for the repayment of debt, with a target reduction of
Updated 2019 Guidance
- Revenue range of
$1.55 billion to $1.56 billion . - Adjusted EBITDA range of
$255 million to $265 million . - Capital expenditures as percent of revenue of approximately 2.5%.
- Capital allocation to be prioritized towards debt pre-payment.
- Net leverage expected to be approximately 4.0x at year-end.
Note: Guidance is based on constant currency.
Note on Outlook: The Company has not forecasted net income/(loss) on a forward-looking basis due to the high variability and difficulty in predicting certain items that affect GAAP net income/(loss). Adjusted EBITDA should not be used to predict net income/(loss) as the difference between the two measures is variable.
Please refer to the attached schedules for reconciliations. Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect absolute figures.
(1) – Constant currency is a non-GAAP measure. A reconciliation of constant currency is attached to this release.
(2) – EBITDA is a non-GAAP measure. A reconciliation of EBITDA is attached to this release.
(3) – Adjusted EBITDA is a non-GAAP measure. A reconciliation of Adjusted EBITDA is attached to this release.
(4) –At
(5) – Pass through revenue is defined as postage and postage handling revenue with either zero or nominal margins. LMCE is defined as revenue from the low margin contract exit announced in the third quarter of 2018. A reconciliation of revenue net of pass through revenue and LMCE is attached to this release.
Earnings Conference Call and Audio Webcast
About
Find out more at www.exelatech.com
Follow
Follow
About Non-GAAP Financial Measures: This press release includes constant currency, EBITDA and Adjusted EBITDA, each of which is a financial measure that is not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Forward-Looking Statements: Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, the estimated or anticipated future results and benefits of the Business Combination, future opportunities for the combined company, and other statements that are not historical facts. These statements are based on the current expectations of
Consolidated Balance Sheets
As of
(in thousands of
(Unaudited)
September 30, | December 31, | |||||||
2019 | 2018 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 10,312 | $ | 25,615 | ||||
Restricted cash | 4,913 | 18,239 | ||||||
Accounts receivable, net of allowance for doubtful accounts of $7,021 and $4,359, respectively | 260,438 | 270,812 | ||||||
Related party receivables | 42 | — | ||||||
Inventories, net | 16,996 | 16,220 | ||||||
Prepaid expenses and other current assets | 22,695 | 25,015 | ||||||
Total current assets | 315,396 | 355,901 | ||||||
Property, plant and equipment, net of accumulated depreciation of $171,913 and $154,060, respectively | 119,469 | 132,986 | ||||||
Operating lease right-of-use assets, net | 93,352 | — | ||||||
Goodwill | 609,458 | 708,258 | ||||||
Intangible assets, net | 374,445 | 407,021 | ||||||
Deferred income tax assets | 15,830 | 16,225 | ||||||
Other noncurrent assets | 13,557 | 19,391 | ||||||
Total assets | $ | 1,541,507 | $ | 1,639,782 | ||||
Liabilities and Stockholders' Equity (Deficit) | ||||||||
Liabilities | ||||||||
Current liabilities | ||||||||
Accounts payables | $ | 93,815 | $ | 99,853 | ||||
Related party payables | 274 | 7,735 | ||||||
Income tax payable | — | 1,996 | ||||||
Accrued liabilities | 60,994 | 66,008 | ||||||
Accrued compensation and benefits | 51,819 | 54,583 | ||||||
Accrued interest | 24,602 | 49,071 | ||||||
Customer deposits | 30,161 | 34,235 | ||||||
Deferred revenue | 17,368 | 16,504 | ||||||
Obligation for claim payment | 43,267 | 56,002 | ||||||
Current portion of finance lease liabilities | 15,172 | 17,498 | ||||||
Current portion of operating lease liabilities | 26,604 | — | ||||||
Current portion of long-term debts | 37,237 | 29,237 | ||||||
Total current liabilities | 401,313 | 432,722 | ||||||
Long-term debt, net of current maturities | 1,367,583 | 1,306,423 | ||||||
Finance lease liabilities, net of current portion | 24,159 | 26,738 | ||||||
Pension liabilities | 26,667 | 25,269 | ||||||
Deferred income tax liabilities | 12,677 | 11,212 | ||||||
Long-term income tax liabilities | 2,892 | 3,024 | ||||||
Operating lease liabilities, net of current portion | 71,661 | — | ||||||
Other long-term liabilities | 7,866 | 15,400 | ||||||
Total liabilities | 1,914,818 | 1,820,788 | ||||||
Commitments and Contingencies (Note 10) | ||||||||
Stockholders' equity (deficit) | ||||||||
Common stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 153,486,011 shares issued and 150,698,864 shares outstanding at September 30, 2019 and 152,692,140 shares issued and 150,142,955 shares outstanding at December 31, 2018 | 15 | 15 | ||||||
Preferred stock, par value of $0.0001 per share; 20,000,000 shares authorized; 4,419,233 shares issued and outstanding at September 30, 2019 and 4,569,233 shares issued and outstanding at December 31, 2018 | 1 | 1 | ||||||
Additional paid in capital | 482,018 | 482,018 | ||||||
Less: common stock held in treasury, at cost; 2,787,147 shares at September 30, 2019 and 2,549,185 shares December 31, 2018 | (10,949 | ) | (10,342 | ) | ||||
Equity-based compensation | 48,411 | 41,731 | ||||||
Accumulated deficit | (876,043 | ) | (678,563 | ) | ||||
Accumulated other comprehensive loss: | ||||||||
Foreign currency translation adjustment | (7,786 | ) | (6,565 | ) | ||||
Unrealized pension actuarial losses, net of tax | (8,978 | ) | (9,301 | ) | ||||
Total accumulated other comprehensive loss | (16,764 | ) | (15,866 | ) | ||||
Total stockholders’ deficit | (373,311 | ) | (181,006 | ) | ||||
Total liabilities and stockholders’ deficit | $ | 1,541,507 | $ | 1,639,782 | ||||
Consolidated Statement of Operations
For the Three and Nine Months Ended
(in thousands of
(Unaudited)
Three Months ended September 30, | Nine Months ended September 30, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Revenue | $ | 372,917 | $ | 383,030 | $ | 1,166,841 | $ | 1,186,579 | ||||||||
Cost of revenue (exclusive of depreciation and amortization) | 291,222 | 295,936 | 896,110 | 903,682 | ||||||||||||
Selling, general and administrative expenses | 50,372 | 44,913 | 151,884 | 137,231 | ||||||||||||
Depreciation and amortization | 27,114 | 35,041 | 82,326 | 109,428 | ||||||||||||
Impairment of goodwill and other intangible assets | 99,682 | — | 99,682 | — | ||||||||||||
Related party expense | 1,405 | 759 | 3,454 | 3,267 | ||||||||||||
Operating income (loss) | (96,878 | ) | 6,381 | (66,615 | ) | 32,971 | ||||||||||
Other expense (income), net: | ||||||||||||||||
Interest expense, net | 39,747 | 38,339 | 117,778 | 114,883 | ||||||||||||
Debt modification and extinguishment costs | — | 1,067 | 1,404 | 1,067 | ||||||||||||
Sundry expense (income), net | (10 | ) | (2,571 | ) | 1,028 | (4,961 | ) | |||||||||
Other expense (income), net | 581 | (781 | ) | 4,965 | (4,813 | ) | ||||||||||
Net loss before income taxes | (137,196 | ) | (29,673 | ) | (191,790 | ) | (73,205 | ) | ||||||||
Income tax (expense) benefit | 3,769 | 733 | (5,689 | ) | (4,911 | ) | ||||||||||
Net loss | $ | (133,427 | ) | $ | (28,940 | ) | $ | (197,479 | ) | $ | (78,116 | ) | ||||
Cumulative dividends for Series A Preferred Stock | (884 | ) | (914 | ) | (2,712 | ) | (2,742 | ) | ||||||||
Net loss attributable to common stockholders | $ | (134,311 | ) | $ | (29,854 | ) | $ | (200,191 | ) | $ | (80,858 | ) | ||||
Loss per share: | ||||||||||||||||
Basic and diluted | $ | (0.89 | ) | $ | (0.20 | ) | $ | (1.33 | ) | $ | (0.53 | ) | ||||
Consolidated Statements of Cash Flows
For the Nine Months Ended
(in thousands of
(Unaudited)
Nine Months Ended September 30, | ||||||||
2019 | 2018 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (197,479 | ) | $ | (78,116 | ) | ||
Adjustments to reconcile net loss | ||||||||
Depreciation and amortization | 82,326 | 109,428 | ||||||
Original issue discount and debt issuance cost amortization | 8,730 | 8,062 | ||||||
Debt modification and extinguishment costs | 1,049 | - | ||||||
Impairment of goodwill and other intangible assets | 99,682 | - | ||||||
Provision for doubtful accounts | 4,402 | 2,470 | ||||||
Deferred income tax provision | 1,632 | (3,689 | ) | |||||
Share-based compensation expense | 6,903 | 4,516 | ||||||
Foreign currency remeasurement | (173 | ) | (2,040 | ) | ||||
Loss (gain) on sale of assets | (191 | ) | 1,835 | |||||
Fair value adjustment for interest rate swap | 4,965 | (5,456 | ) | |||||
Change in operating assets and liabilities, net of effect from acquisitions | ||||||||
Accounts receivable | 3,501 | (6,374 | ) | |||||
Prepaid expenses and other assets | 2,377 | (5,770 | ) | |||||
Accounts payable and accrued liabilities | (43,861 | ) | (23,457 | ) | ||||
Related party payables | (7,502 | ) | (3,689 | ) | ||||
Net cash used in operating activities | (33,639 | ) | (2,280 | ) | ||||
Cash flows from investing activities | ||||||||
Purchase of property, plant and equipment | (10,797 | ) | (14,077 | ) | ||||
Additions to internally developed software | (5,074 | ) | (3,080 | ) | ||||
Additions to outsourcing contract costs | (14,304 | ) | (5,427 | ) | ||||
Cash paid in acquisition, net of cash received | (5,000 | ) | (6,513 | ) | ||||
Proceeds from sale of assets | 360 | 1,095 | ||||||
Net cash used in investing activities | (34,815 | ) | (28,002 | ) | ||||
Cash flows from financing activities | ||||||||
Third party debt modification and extinguishment costs | 355 | 1,067 | ||||||
Repurchases of common stock | (3,480 | ) | (4,899 | ) | ||||
Borrowings from other loans | 1,728 | 3,068 | ||||||
Cash paid for equity issuance costs | - | (7,500 | ) | |||||
Net borrowings under factoring arrangement | (494 | ) | - | |||||
Cash paid for withholding taxes on vested RSUs | (223 | ) | - | |||||
Proceeds from senior secured term loans | 29,850 | 30,000 | ||||||
Cash paid for debt issuance costs | (362 | ) | (1,094 | ) | ||||
Borrowings from senior secured revolving facility | 130,500 | 30,000 | ||||||
Repayments on senior secured revolving facility | (91,500 | ) | (30,000 | ) | ||||
Principal payments on finance lease obligations | (13,598 | ) | (12,594 | ) | ||||
Principal repayments on senior secured term loans and other loans | (12,922 | ) | (9,053 | ) | ||||
Net cash provided by (used in) financing activities | 39,854 | (1,005 | ) | |||||
Effect of exchange rates on cash | (29 | ) | (554 | ) | ||||
Net decrease in cash and cash equivalents | (28,629 | ) | (31,842 | ) | ||||
Cash, restricted cash, and cash equivalents | ||||||||
Beginning of period | 43,854 | 81,489 | ||||||
End of period | $ | 15,225 | $ | 49,647 | ||||
Supplemental cash flow data: | ||||||||
Income tax payments, net of refunds received | $ | 6,981 | $ | 5,296 | ||||
Interest paid | 131,773 | 136,396 | ||||||
Noncash investing and financing activities: | ||||||||
Assets acquired through right-of-use arrangements | 9,352 | 9,318 | ||||||
Leasehold improvements funded by lessor | - | 1,565 | ||||||
Accrued capital expenditures | 1,083 | 1,994 | ||||||
Schedule 1: Reconciliation of Adjusted EBITDA and constant currency revenues (Unaudited)
Reconciliation of Non-GAAP Financial Measures to GAAP Measures | ||||||||||||||||
Non-GAAP constant currency revenue reconciliation | ||||||||||||||||
($ in millions) | Three months ended | Nine months ended | ||||||||||||||
30-Sep-19 | 30-Sep-18 | 30-Sep-19 | 30-Sep-18 | |||||||||||||
Revenues, as reported (GAAP) | $372.9 | $383.0 | $1,166.8 | $1,186.6 | ||||||||||||
Foreign currency exchange impact (1) | 3.0 | 13.4 | ||||||||||||||
Revenues, at constant currency (Non-GAAP) | $375.9 | $383.0 | $1,180.2 | $1,186.6 | ||||||||||||
(1) Constant currency excludes the impact of foreign currency fluctuations and is computed by applying the average exchange rates for the three months and nine months ended September 30, 2018, to the revenues during the corresponding period in 2019. | ||||||||||||||||
Reconciliation of Adjusted EBITDA | ||||||||||||||||
($ in millions) | Three months ended | Nine months ended | ||||||||||||||
30-Sep-19 | 30-Sep-18 | 30-Sep-19 | 30-Sep-18 | |||||||||||||
Net loss (GAAP) | ($133.4 | ) | ($28.9 | ) | ($197.5 | ) | ($78.2 | ) | ||||||||
Interest expense | 39.7 | 38.3 | 117.8 | 114.9 | ||||||||||||
Taxes | (3.8 | ) | (0.7 | ) | 5.7 | 4.9 | ||||||||||
Depreciation and amortization | 27.1 | 35.0 | 82.3 | 109.4 | ||||||||||||
EBITDA (Non-GAAP) | ($70.3 | ) | $43.7 | $8.3 | $151.0 | |||||||||||
Transaction and integration costs | 1.2 | 0.2 | 4.2 | 2.1 | ||||||||||||
Optimization and restructuring expenses | 16.8 | 16.5 | 59.2 | 35.1 | ||||||||||||
Gain / loss on derivative instruments | 0.6 | (0.8 | ) | 5.0 | (4.8 | ) | ||||||||||
Other Charges | 110.3 | 9.2 | 125.4 | 25.0 | ||||||||||||
Adjusted EBITDA (Non-GAAP) | $58.5 | $68.9 | $202.1 | $208.4 | ||||||||||||
Foreign currency exchange impact (1) | 0.1 | 1.1 | - | |||||||||||||
Adjusted EBITDA, at constant currency (Non-GAAP) | $58.7 | $68.9 | $203.1 | $208.4 | ||||||||||||
(1) Constant currency excludes the impact of foreign currency fluctuations and is computed by applying the average exchange rates for the three months and nine months ended September 30, 2018, to the adjusted EBITDA during the corresponding period in 2019. | ||||||||||||||||
Schedule 2: Non-GAAP Revenue reconciliation & Adjusted EBITDA margin on Revenue net of pass through & LMCE (Unaudited)
Non-GAAP revenue reconciliation & Adjusted EBITDA margin on revenue net of pass through & LMCE | ||||||||||||||||
($ in millions) | Three months ended | Nine months ended | ||||||||||||||
30-Sep-19 | 30-Sep-18 | 30-Sep-19 | 30-Sep-18 | |||||||||||||
Revenues, as reported (GAAP) | $372.9 | $383.0 | $1,166.8 | $1,186.6 | ||||||||||||
(-) Postage & postage handling | 63.6 | 76.9 | 205.3 | 232.9 | ||||||||||||
Revenue - Net of pass through (Non-GAAP) | $309.3 | $306.2 | $961.6 | $953.6 | ||||||||||||
(-) LMCE | - | 4.2 | 2.1 | 24.3 | ||||||||||||
Revenue - Net of pass through & LMCE (Non-GAAP) | $309.3 | $302.0 | $959.5 | $929.3 | ||||||||||||
Revenue growth % | 2.4 | % | 3.2 | % | ||||||||||||
Adjusted EBITDA (Non-GAAP) | $58.5 | $68.9 | $202.1 | $208.4 | ||||||||||||
Adjusted EBITDA margin | 18.9 | % | 22.8 | % | 21.1 | % | 22.4 | % | ||||||||
Contact:
E: ir@exelatech.com
W: investors.exelatech.com
T: +1 646-277-1236
Source: Exela Technologies, Inc.